Poster: Advanced Therapies London 2025

Controlling cell-to-cell adhesion to facilitate process optimisation and intensification

As presented by our Head of Technology at Advanced Therapies London in 2025, this poster provides an overview of the transformative benefits of AggreGuard on microcarrier-based cultures.

Related Blogs

(Newcastle Upon Tyne, 11th June 2025) The Kuraray Life Innovation Business Promotion Department, a division of Kuraray Co., Ltd. (TYO: 3406), a …

Except for hematopoietic-derived cells, most cells isolated from animals are naturally adherent. In vivo, adherent cells interact with their surrounding environment and …

CellRev launches its proprietary media additive AggreGuard™ which prevents aggregation of adherent cells and increases cell yield in existing VERO processes CellRev, …

Share